HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective …

…, P Geijo-Martinez, M Montero-Alonso… - HIV Clinical …, 2017 - Taylor & Francis
Objective: HIV/HCV-coinfected patients and hepatitis C virus (HCV) monoinfected subjects
are thought to respond equally to direct-acting antiviral (DAA)-based therapy despite the lack …

Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti …

…, JR Blanco, F Gutierrez, M Montero Alonso… - …, 2016 - Wiley Online Library
Aims To compare patients who acquired HIV infection through use of injected drugs (HIV‐IDU)
with patients who acquired HIV by sexual transmission (HIV‐ST) in terms of late …

[HTML][HTML] Monocyte activation and ageing biomarkers in the development of cardiovascular ischaemic events or diabetes in people with HIV

…, R Montejano, R De Miguel, M Montero-Alonso… - Microorganisms, 2023 - mdpi.com
We investigated whether blood telomere length (TL), epigenetic age acceleration (EAA),
and soluble inflammatory monocyte cytokines are associated with cardiovascular events or …

[HTML][HTML] IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

…, S Moreno, T Aldamiz, M Montero-Alonso… - Frontiers in …, 2023 - frontiersin.org
Background Interferon-inducible protein-10 (IP-10) and monokine induced by interferon-gamma
(MIG) are chemokines recognized as inflammatory biomarkers during HIV-1 infection. …

[HTML][HTML] Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct …

…, A Hernanz-Lobo, M Montero-Alonso… - Biomedicine & …, 2023 - Elsevier
This study aimed to analyse the long-term effect of direct-acting antivirals (DAAs) in vertically
acquired HIV/HCV-coinfected youths. We performed a multicentre, longitudinal and …

Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

…, M López‐Dupla, M Montero Alonso… - HIV …, 2022 - Wiley Online Library
Objectives To pinpoint factors associated with low‐level viraemia (LLV) and virological failure
(VF) in people living with HIV in the era of high‐efficacy antiretroviral treatment (ART) and …

[HTML][HTML] Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

…, M Gutiérrez-Rivas, A León, M Montero-Alonso… - Journal of Microbiology …, 2019 - Elsevier
Exosome-derived miR-21 was independently associated with CD4 T cell decline in HIV-1-infected
elite controllers (OR 0.369, 95% CI 0.137–0.994, p = 0.049). Also, a negative …

Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2

…, L Martinez-Priego, M Guerreiro, M Montero-Alonso… - Mbio, 2021 - Am Soc Microbiol
We have detected two mutations in the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) at amino acid positions 1163 and 1167 that appeared …

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV …

…, A Curran, L Morano, M Montero-Alonso… - Journal of …, 2023 - academic.oup.com
Objectives To evaluate the efficacy and safety of the two-pill regimen bictegravir/emtricitabine/tenofovir
alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat as a switching strategy in …

Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain

…, J Moltó-Marhuenda, M Montero-Alonso… - … y Microbiología Clínica, 2023 - Elsevier
Background People with HIV (PWH) in suppressive antiretroviral treatment suffer from chronic
inflammation-related comorbidities, mainly cardiovascular diseases. However, given the …